Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

NCX-530 is less toxic than indomethacin to the intestine according to rat studies

Feb. 12, 2001

SCIO-469 now being studied in phase Ib trial for treatment of RA

Feb. 9, 2001

Combinations of etanercept and a COX-2 inhibitor claimed by Pharmacia for Rx of inflammation

Feb. 7, 2001

Pyrazole-based inhibitors of p38 MAP kinase identified at Teikoku Hormone

Feb. 6, 2001

E.U. approves Remicade for broader RA indication

Feb. 6, 2001

Overseas development of TR-14035 to be managed by GlaxoSmithKline

Feb. 5, 2001

New MMP-inhibitory hydroxamic acid derivatives and use thereof

Feb. 2, 2001

Dimethaid begins mutual recognition procedure in E.U. for Pennsaid

Feb. 2, 2001

Patent assigned to Warner-Lambert covers MMP inhibitors for various disorders

Feb. 1, 2001

COX-2 inhibitors as antiinflammatory, analgesic agents presented by Pfizer

Feb. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.